News Clearside Biomedical, Inc.

Equities

CLSD

US1850631045

Market Closed - Nasdaq Other stock markets 21:00:00 26/06/2024 BST			5-day change	1st Jan Change
1.21 ^USD	-3.20%		+8.04%	+3.42%

06-25	Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target	MT
05-13	HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target	06-25	MT
Clearside Biomedical : 2024 Proxy Statement	06-19	PU
Clearside Biomedical's Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting	06-13	AQ
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting	06-12	AQ
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space Injection in Leading Peer-Reviewed Industry Journal, RETINA	05-22	AQ
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®	05-21	AQ
HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating	05-13	MT
Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024	05-09
Clearside Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update	05-09	AQ
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference	05-08	AQ
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024	04-30	AQ
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors	04-16	AQ
Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors	04-16	CI
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	04-02	AQ
Clearside Biomedical Names Victor Chong Chief Medical Officer	03-18	MT
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer	03-18	AQ
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer	03-18	CI
Wedbush Trims Clearside Biomedical's PT to $4 From $5 After Increased Share Count, Model Adjustments; Maintains Outperform Rating	03-13	MT
Clearside Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Clearside Biomedical, Inc.

Equities

CLSD

US1850631045

Summary

Filters